Home > Compound List > Compound details
34839-70-8 molecular structure
click picture or here to close

3-methyl-1-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)thiourea

ChemBase ID: 6405
Molecular Formular: C9H16N4S2
Molecular Mass: 244.38014
Monoisotopic Mass: 244.08163853
SMILES and InChIs

SMILES:
S(Cc1nc[nH]c1C)CCNC(=S)NC
Canonical SMILES:
CNC(=S)NCCSCc1nc[nH]c1C
InChI:
InChI=1S/C9H16N4S2/c1-7-8(13-6-12-7)5-15-4-3-11-9(14)10-2/h6H,3-5H2,1-2H3,(H,12,13)(H2,10,11,14)
InChIKey:
FPBPLBWLMYGIQR-UHFFFAOYSA-N

Cite this record

CBID:6405 http://www.chembase.cn/molecule-6405.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
3-methyl-1-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)thiourea
IUPAC Traditional name
metiamide
methiamide
Synonyms
Methiamide
Metiamidum
Metiamida
Metiamide
CAS Number
34839-70-8
PubChem SID
160969712
PubChem CID
1548992
CHEMBL
275446
Chemspider ID
1265996
DrugBank ID
DB08805
Wikipedia Title
Metiamide

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 12.478477  H Acceptors
H Donor LogD (pH = 5.5) -0.5725445 
LogD (pH = 7.4) 0.23148139  Log P 0.3414594 
Molar Refractivity 70.3953 cm3 Polarizability 26.881952 Å3
Polar Surface Area 52.74 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 0.5  LOG S -3.93 
Solubility (Water) 2.87e-02 g/l 

PROPERTIES

PROPERTIES

Bioassay(PubChem)

DETAILS

DETAILS

DrugBank DrugBank Wikipedia Wikipedia
DrugBank - DB08805 external link
Item Information
Drug Groups experimental
Description Metiamide is a histamine H2-receptor antagonist developed from another H2 antagonist, burimamide. It was an intermediate compound in the development of the successful anti-ulcer drug cimetidine.
Indication Potential in the treatment and the management of acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion.
Pharmacology Metiamide is a histamine H2-receptor antagonist. It reduces basal and nocturnal gastric acid secretion and a reduction in gastric volume, acidity, and amount of gastric acid released in response to stimuli including food, caffeine, insulin, betazole, or pentagastrin. Metiamide inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Metiamide include an increase in gastric bacterial flora such as nitrate-reducing organisms.
External Links
Wikipedia

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle